Actinogen Medical Limited (ASX:ACW) has been placed in a trading halt at the company's request, effective 13 November 2026, pending the release of an announcement by the company, according to a filing issued by ASX Supervision.

Key Points

  • Trading in Actinogen Medical securities was halted on 13 November 2026 at the company's request.
  • The halt is pending the release of an announcement by ACW.
  • Securities will remain in trading halt until the earlier of the commencement of normal trading on Tuesday, 17 November 2026, or the release of the announcement to the market.
  • ASX Supervision issued the trading halt notice, with ACW's request attached for the information of the market.

Trading Halt Details

ASX Supervision confirmed that trading in the securities of Actinogen Medical Limited was halted on 13 November 2026 following a request submitted by the company. The halt was initiated pending the release of a market announcement by ACW. The filing states that unless ASX decides otherwise, the trading halt will remain in place until the earlier of two specified conditions are met, with the latest possible resumption being the commencement of normal trading on Tuesday, 17 November 2026.

Conditions for Resumption of Trading

According to the filing, Actinogen Medical's securities will remain subject to the trading halt until either normal trading commences on Tuesday, 17 November 2026, or the company releases its pending announcement to the market, whichever occurs earlier. ASX retains the ability to determine otherwise regarding the duration or lifting of the halt. No further details regarding the nature or content of the anticipated announcement were disclosed in the filing.

Company Request and ASX Supervision Notice

The trading halt was enacted at the request of Actinogen Medical Limited, with ACW's formal request attached to the notice for the information of the market. The notice was issued by ASX Supervision on 13 November 2026. The filing does not disclose any information about the subject matter of the forthcoming announcement or any other operational, financial, or corporate details pertaining to Actinogen Medical at this time.